Autonomix Medical, Inc. to Present at the Virtual Investor Event Titled “A Breakthrough Medical Device for the Diagnosis and Treatment of Diseases of the Nervous System”
06 déc. 2023 14h00 HE
|
Autonomix Medical, Inc.
Live moderated video webcast on Monday, December 11 at 2:00 PM ET THE WOODLANDS, TX, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device...
Tulathromycin Market to Reach USD 457.82 Million by 2030: Straits Research
08 avr. 2022 08h00 HE
|
Straits Research
New York, United States, April 08, 2022 (GLOBE NEWSWIRE) -- The tulathromycin market had a market share of USD 265.72 million in 2020, according to the new report of Straits Research. It is...